4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-011075
Chief Scientific Officer sold 25,900 shares at an average $31.76 ($822,679)
- Chief Scientific Officer acquired 25,900 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2020-02-18 | Option exercise | +18,500 | $6.32 | $116,920 | 89,179 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2020-02-18 | Sale | −18,500 | $31.38 | $580,530 | 70,679 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2020-02-19 | Option exercise | +7,400 | $6.32 | $46,768 | 78,079 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2020-02-19 | Sale | −3,500 | $32.18 | $112,630 | 74,579 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2020-02-19 | Sale | −3,900 | $33.21 | $129,519 | 70,679 | D |
| Derivatives | |||||||
| ROBINS HARLAN S Chief Scientific Officer | 2020-02-18 | Option exercise · Stock Option (Right to Buy) | −18,500 | 570,400 | D | ||
| ROBINS HARLAN S Chief Scientific Officer | 2020-02-19 | Option exercise · Stock Option (Right to Buy) | −7,400 | 563,000 | D | ||
| Open-market sales · 25,900 sh · avg $31.76 · $822,679 | |||||||
Loading xslF345X03/doc4.xml…